Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 3Leiomyoma 2cyclopia sequence 1Vomiting 1Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Pancreatic Neoplasms 1Pain 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Nausea 1Myasthenia Gravis 1Melanoma 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Lung Neoplasms 1Lower Urinary Tract Symptoms 1Insulin Resistance 1Infertility 1Hyperandrogenism 1Hot Flashes 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Diarrhea 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Tamoxifen 3Mastectomy, Segmental 2Immunohistochemistry 2talimogene laherparepvec 1abemaciclib 1Surgical Procedures, Operative 1Sugars 1Specimen Handling 1Radiotherapy 1Radiation 1Nivolumab 1Naltrexone 1Mass Spectrometry 1Lovastatin 1Ipilimumab 1Infliximab 1Hypericum extract LI 160 1Genotype 1Gels 1Gefitinib 1Fluorescent Antibody Technique 1Flow Cytometry 1Chromatography, Liquid 1Chemotherapy, Adjuvant 1Celecoxib 1CTLA-4 Antigen 1Brachytherapy 1Biopsy, Needle 1Biopsy, Fine-Needle 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Breast Carcinoma In Situ × Sugars × Clear all
NCT02137252 2021-11-16

Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer

Dana-Farber Cancer Institute

Phase 2 Terminated
3 enrolled 4 charts
Breast

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡